Article
Molecular Therapies for Choroideremia
23 Sept 2019
Abstract excerpt
Advances in molecular research have culminated in the development of novel gene-based therapies for inherited retinal diseases. We have recently witnessed several groundbreaking clinical studies that ultimately led to approval of Luxturna, the first gene therapy for an inherited retinal disease. In parallel, international research community has been engaged in conducting gene therapy trials for another more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
